A S Silva1, D Ariza1, D P M Dias2, C C Crestani3, M C Martins-Pinge4. 1. Departamento de Ciências Fisiológicas, Universidade Estadual de Londrina - UEL, Londrina, PR, Brazil. 2. Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Fisiologia, Laboratório de Fisiologia Cardiovascular, Ribeirão Preto, SP, Brazil. 3. Faculdade de Ciências Farmacêuticas da Universidade Estadual Paulista (UNESP), Araraquara, SP, Brazil. 4. Departamento de Ciências Fisiológicas, Universidade Estadual de Londrina - UEL, Londrina, PR, Brazil. Electronic address: martinspinge@uel.br.
Abstract
OBJECTIVE: Evaluate the effects caused by L-DOPA on cardiovascular and autonomic parameters in an animal model of Parkinsonism induced by 6-hydroxydopamine (6-OHDA). METHODS: Adult male Wistar rats were subjected to bilateral microinfusion of 6-OHDA or saline (sham group) in the substantia nigra, and treated by gavage with L-DOPA or water for 7 days after surgery. On the 6th day the rats were subjected to femoral artery catheterization for cardiovascular recording. Mean arterial pressure (MAP) and heart rate (HR) were evaluated at baseline and during head up tilt (HUT) protocol. Spectral analysis of cardiovascular variability was performed using the V2.4 CardioSeries software v2.4. The lesion was quantified by dopamine levels in the striatum. RESULTS: Dopamine levels in the striatum were decreased in 6-OHDA rats (sham: 4.79 ± 0.49 ng/mg; 6-OHDA: 1.99 ± 0.68 ng/mg) and were not recovered by Prolopa treatment. Baseline values of MAP and HR were not different between groups. HUT induced an increase in MAP and HR (ΔMAP: 17 ± 1 mm Hg, ΔHR: 39 ± 4 bpm) that were attenuated in 6-OHDA and in Prolopa treated animals. At baseline, the systolic arterial pressure (SAP) variance was lower in the 6-OHDA AND sham prolopa groups. Spontaneous baroreflex sensitivity was higher at baseline in the 6-OHDA group as compared to all studied groups. CONCLUSIONS: Our data suggest that treatment with Prolopa did not interfere with cardiovascular variables at baseline. However, during HUT, the 6-OHDA and Prolopa control animals presented a lower cardiovascular compensation, suggesting a possible autonomic impairment in Parkinsonism induced by 6-OHDA.
OBJECTIVE: Evaluate the effects caused by L-DOPA on cardiovascular and autonomic parameters in an animal model of Parkinsonism induced by 6-hydroxydopamine (6-OHDA). METHODS: Adult male Wistar rats were subjected to bilateral microinfusion of 6-OHDA or saline (sham group) in the substantia nigra, and treated by gavage with L-DOPA or water for 7 days after surgery. On the 6th day the rats were subjected to femoral artery catheterization for cardiovascular recording. Mean arterial pressure (MAP) and heart rate (HR) were evaluated at baseline and during head up tilt (HUT) protocol. Spectral analysis of cardiovascular variability was performed using the V2.4 CardioSeries software v2.4. The lesion was quantified by dopamine levels in the striatum. RESULTS:Dopamine levels in the striatum were decreased in 6-OHDArats (sham: 4.79 ± 0.49 ng/mg; 6-OHDA: 1.99 ± 0.68 ng/mg) and were not recovered by Prolopa treatment. Baseline values of MAP and HR were not different between groups. HUT induced an increase in MAP and HR (ΔMAP: 17 ± 1 mm Hg, ΔHR: 39 ± 4 bpm) that were attenuated in 6-OHDA and in Prolopa treated animals. At baseline, the systolic arterial pressure (SAP) variance was lower in the 6-OHDA AND sham prolopa groups. Spontaneous baroreflex sensitivity was higher at baseline in the 6-OHDA group as compared to all studied groups. CONCLUSIONS: Our data suggest that treatment with Prolopa did not interfere with cardiovascular variables at baseline. However, during HUT, the 6-OHDA and Prolopa control animals presented a lower cardiovascular compensation, suggesting a possible autonomic impairment in Parkinsonism induced by 6-OHDA.
Entities:
Keywords:
Arterial pressure; Head up tilt; Heart rate; Prolopa; Variability
Authors: Rafaela Moreira Barbosa; Guilherme F Speretta; Daniel Penteado Martins Dias; Prashant Jay Ruchaya; Hongwei Li; José Vanderlei Menani; Colin Sumners; Eduardo Colombari; Débora S A Colombari Journal: Am J Hypertens Date: 2017-04-01 Impact factor: 2.689
Authors: Michael F Salvatore; Isabel Soto; Ella A Kasanga; Rachael James; Marla K Shifflet; Kirby Doshier; Joel T Little; Joshia John; Helene M Alphonso; J Thomas Cunningham; Vicki A Nejtek Journal: J Parkinsons Dis Date: 2022 Impact factor: 5.520
Authors: Fulvio A Scorza; Andrea C do Carmo; Ana C Fiorini; Mariana B Nejm; Carla A Scorza; Josef Finsterer; Henrique B Ferraz Journal: Clinics (Sao Paulo) Date: 2017-11 Impact factor: 2.365
Authors: Ajay K Verma; Da Xu; Michelle Bruner; Amanmeet Garg; Nandu Goswami; Andrew P Blaber; Kouhyar Tavakolian Journal: Front Physiol Date: 2018-06-25 Impact factor: 4.566
Authors: Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza Journal: Nutrients Date: 2020-05-26 Impact factor: 5.717